| Title: | Effect of vitamin D supplementation on cardiovascular outcomes: randomized trials revisited |
| Journal: | European Journal of Epidemiology |
| Published: | 22 Jul 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/42484779/ |
| DOI: | https://doi.org/10.1007/s10654-026-01438-7 |
| URL: | https://link.springer.com/content/pdf/10.1007/s10654-026-01438-7.pdf |
Publication 21418
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
This study aims to estimate the effects of vitamin D supplementation on cardiovascular diseases in populations with different baseline vitamin D distributions, by emulating the VITAL and D-Health trials within the UK Biobank. We emulated randomized trials using subcohorts of the UK Biobank selected to match the inclusion criteria of the VITAL and D-Health trials (n = 237,502 and 185,809, respectively). Exposures were defined as increases in serum 25-hydroxyvitamin-D concentrations of 30 nmol/L and 38 nmol/L, corresponding to the intervention effects in the trials. Outcomes included cardiovascular mortality, myocardial infarction, ischemic stroke, and major adverse cardiovascular events. Expected hazard ratios over trial median follow-up durations of 5.3 and 5.7 years were estimated using Cox proportional hazards models. Vitamin D insufficiency was more common in the UK Biobank than in the original trials. When participants were weighted to match the trial baseline 25-hydroxyvitamin-D distributions, the expected effects became more similar to the largely null findings reported in the original trials. By contrast, among individuals with vitamin D insufficiency or deficiency, increases in 25-hydroxyvitamin-D concentration as achieved in the trials were associated with significantly lower risks of cardiovascular outcomes, except ischemic stroke. For cardiovascular mortality, hazard ratios ranged from 0.74 (95% CI 0.62-0.88) to 0.79 (95% CI 0.69-0.91) across both trial emulations. The largely null findings observed in the trials may partly reflect that the trial populations were predominantly vitamin D-replete. Our emulated trials suggest that substantial cardiovascular benefits from vitamin D supplementation may be expected among populations with low vitamin D status.</p>
5 Authors
- Youqing Wang
- Sha Sha
- Tafirenyika Gwenzi
- Ben Schöttker
- Hermann Brenner
1 Application
| Application ID | Title |
|---|---|
| 89329 | Pharmacoepidemiological research in the UK Biobank |
Enabling scientific discoveries that improve human health